Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Pathway Study for Oxaliplatin Resistance Reduction. | Curr Issues Mol Biol | 2025 | 40136426 | PubTator, text mining | PubMed |
| Pan-cancer analysis of CDC7 in human tumors: Integrative multi-omics insights and discovery of novel marine-based inhibitors through machine learning and computational approaches. | Comput Biol Med | 2025 | 40120182 | PubTator, text mining | PubMed |
| Recent advances in CDC7 kinase inhibitors: Novel strategies for the treatment of cancers and neurodegenerative diseases. | Eur J Med Chem | 2025 | 40090297 | PubTator, text mining | PubMed |
| Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer. | PeerJ | 2025 | 40034665 | PubTator, text mining | PubMed |
| Experimental, Theoretical, and In Silico Studies of Potential CDC7 Kinase Inhibitors. | ACS Omega | 2025 | 39829445 | PubTator, text mining | PubMed |
| The Genomic Landscape of Wilson Disease in a Pan India Disease Cohort and Population-Scale Data. | Mov Disord Clin Pract | 2025 | 39535360 | PubTator, text mining | PubMed |
| The molecular determinants of phenotypic plasticity in homeostasis and neoplasia. | Cancer Heterog Plast | 2024 | 40994652 | PubTator, text mining | PubMed |
| CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer. | Adv Sci (Weinh) | 2024 | 39412086 | PubTator, text mining | PubMed |
| Assembly, Activation, and Helicase Actions of MCM2-7: Transition from Inactive MCM2-7 Double Hexamers to Active Replication Forks. | Biology (Basel) | 2024 | 39194567 | PubTator, text mining | PubMed |
| CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation. | Signal Transduct Target Ther | 2024 | 39054323 | PubTator, text mining | PubMed |
| DBF4, not DRF1, is the crucial regulator of CDC7 kinase at replication forks. | J Cell Biol | 2024 | 38865090 | PubTator, text mining | PubMed |
| Correlative single molecule lattice light sheet imaging reveals the dynamic relationship between nucleosomes and the local chromatin environment. | Nat Commun | 2024 | 38755200 | PubTator, text mining | PubMed |
| RAD18 O-GlcNAcylation promotes translesion DNA synthesis and homologous recombination repair. | Cell Death Dis | 2024 | 38719812 | PubTator, text mining | PubMed |
| CK1δ/ε kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation. | Neurobiol Dis | 2024 | 38677657 | PubTator, text mining | PubMed |
| Hi-C, a chromatin 3D structure technique advancing the functional genomics of immune cells. | Front Genet | 2024 | 38586584 | PubTator, text mining | PubMed |
| CDC7 inhibition drives an inflammatory response and a p53-dependent senescent-like state in breast epithelial cells. | FEBS J | 2024 | 38555567 | PubTator, text mining | PubMed |
| Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer. | Adv Sci (Weinh) | 2024 | 38520730 | PubTator, text mining | PubMed |
| Epidemiological and transcriptome data identify shared gene signatures and immune cell infiltration in type 2 diabetes and non-small cell lung cancer. | Diabetol Metab Syndr | 2024 | 38468345 | PubTator, text mining | PubMed |
| Potts Hamiltonian Models and Molecular Dynamics Free Energy Simulations for Predicting the Impact of Mutations on Protein Kinase Stability. | J Phys Chem B | 2024 | 38350894 | PubTator, text mining | PubMed |
| Discovery of a potent and selective cell division cycle 7 inhibitor from 6-(3-fluoropyridin-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as an orally active antitumor agent. | Acta Pharm Sin B | 2024 | 38322352 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=3